Key facts
- Salubrum’s last known valuation is $2.0M (Sep 2025).
- It has raised $150K; the latest was Early Stage VC in Sep 2025.
- Notable investors include Right Side Capital Management, Forum Ventures, Airtable, Coeus Collective Ventures, Next (Consulting Services) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Salubrum
- ·The full record, as it builds
Funding rounds
No funding rounds for Salubrum are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salubrum
Developer of a healthcare demand intelligence platform designed to predict consumer behaviour and support targeted engagement. The company's platform offers intent scoring based on real-world engagement data and patient identity mapping, enabling healthcare brands to identify high-intent consumers and improve acquisition efforts.
- Sector
- Business Products and Services (B2B)
- HQ
- Newmarket, Canada
- Founded
- 2023
- Employees
- 8
- Website
- salubrum.com/
- Ownership
- Privately Held (backing)
Salubrum doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salubrum shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salubrum in its N-PORT filings yet. We sweep new filings monthly.